Skip to content

The clinical evaluation and verification study of multiple molecular regulatory network based on circRNA-miRNA in the early-onset schizophrenia

The clinical evaluation and verification study of multiple molecular regulatory network based on circRNA-miRNA in the early-onset schizophrenia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900025597
Enrollment
Unknown
Registered
2019-09-02
Start date
2019-09-01
Completion date
Unknown
Last updated
2019-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early-onset schizophrenia

Interventions

early-onset schizophrenia:Standardized antipsychotic treatment for 12 weeks

Sponsors

The First Hospital of Shanxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
7 Years to 18 Years

Inclusion criteria

Inclusion criteria: EOS: The Han nationality aged 7 to 18 years old; First-Episode Patients without treatment, or nearly 3 months without using of antipsychotic treatment in patients with early-onset schizophrenia; using the standardized DSM-IV-TR axis I disorder stereotyping clinical examination (SCID) as a screening tool and forming the DSM-? diagnosis criteria for schizophrenia (Diagnostic and Statistical Manual of Mental Disorders, Forth edition, American Psychiatric Association); patients with consistent diagnosis who are independent diagnosed by two attending or above-level physicians respectively; positive and negative symptoms scale (PANSS) score >=70; patients and their families agree to participate in this study. Healthy control: Agreeing to participate in this study and signing the informed consent;the han nationality; more than 7 and less than 18 years old; no mental disorder diagnosised by the standardized DSM-IV-TR axis I disorder stereotyping clinical examination (SCID); no mental disorder or hereditary nervous system disease in two families and three generations of relatives; matched with the patient group according to age, sex and years of education.

Exclusion criteria

Exclusion criteria: EOS: Pregnant or lactating women;history of head injury and major body disease;with other neural psychiatric disorders;receiving modified electric convulsive therapy(MECT), therapy of antipsychotic or antidepressants in 6 months. Healthy control: History of brain organic diseases or other clinically significant physical illness; history of head injury and loss of consciousness for more than 30 minutes;abuse of alcohol or dependence of other substances; having participated in other drug clinical trials within 30 days; obvious abnormal laboratory results (except for liver and kidney function, the results of laboratory examination are more 1.5 times than the normal value).

Design outcomes

Primary

MeasureTime frame
clinical information;Cognitive data;

Countries

China

Contacts

Public ContactSha Liu

The First Hospital of Shanxi Medical University

liusha1984114@163.com+86 19834513598

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026